122 related articles for article (PubMed ID: 32877662)
1. 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.
Lu J; Zhou Y; Zheng X; Chen L; Tuo X; Chen H; Xue M; Chen Q; Chen W; Li X; Zhao L
Arch Biochem Biophys; 2020 Oct; 693():108569. PubMed ID: 32877662
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.
Lu J; Chen H; He F; You Y; Feng Z; Chen W; Li X; Zhao L
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1455-1463. PubMed ID: 32271958
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer.
Zheng X; Chen W; Hou H; Li J; Li H; Sun X; Zhao L; Li X
Biomed Pharmacother; 2017 Jan; 85():620-626. PubMed ID: 27899249
[TBL] [Abstract][Full Text] [Related]
6. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract][Full Text] [Related]
7. [Effect of miR-145 on Migration and Invasion of Ovarian Cancer Cells].
Li J; Zhou YY; Zhao L; Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):581-588. PubMed ID: 31699186
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
[TBL] [Abstract][Full Text] [Related]
9. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals.
Liu T; Zhao L; Hou H; Ding L; Chen W; Li X
Tumour Biol; 2017 May; 39(5):1010428317692225. PubMed ID: 28459376
[TBL] [Abstract][Full Text] [Related]
11. Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells.
Zhao L; Shou H; Chen L; Gao W; Fang C; Zhang P
Oncol Rep; 2019 Jun; 41(6):3209-3218. PubMed ID: 31002353
[TBL] [Abstract][Full Text] [Related]
12. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside 20(S)‑Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells.
Li J; Liu T; Zhao L; Chen W; Hou H; Ye Z; Li X
Int J Oncol; 2015 Feb; 46(2):775-81. PubMed ID: 25405516
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
16. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p.
Zhou Y; Jin Z; Wang C
Biomed Pharmacother; 2019 Dec; 120():109449. PubMed ID: 31627092
[TBL] [Abstract][Full Text] [Related]
17. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1.
Nakae A; Kodama M; Okamoto T; Tokunaga M; Shimura H; Hashimoto K; Sawada K; Kodama T; Copeland NG; Jenkins NA; Kimura T
Biochem Biophys Res Commun; 2021 May; 552():120-127. PubMed ID: 33744759
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2.
Xie HH; Huan WT; Han JQ; Ren WR; Yang LH
Biol Res; 2019 Apr; 52(1):18. PubMed ID: 30944041
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Kanlikilicer P; Rashed MH; Bayraktar R; Mitra R; Ivan C; Aslan B; Zhang X; Filant J; Silva AM; Rodriguez-Aguayo C; Bayraktar E; Pichler M; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
Cancer Res; 2016 Dec; 76(24):7194-7207. PubMed ID: 27742688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
